JPM-OEt (Standard)
JPM-OEt (Standard) is the analytical standard of JPM-OEt (HY-102087). This product is intended for research and analytical applications. JPM-OEt is a broad spectrum cysteine cathepsin inhibitor. JPM-OEt binds covalently in the active site, and irreversibly inhibits the cysteine cathepsin family. Antitumor activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 262381-84-0
- Fòrmula: C20H28N2O6
- Peso molecular:392.45
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-D0843
N-EthylmaleimideCysteine Residues Modifier -
HY-148905
p-Aminophenylmercuric acetateMatrix Metalloproteinases Activator -
HY-100350
CA-074 methyl esterCathepsin B Inhibitor -
HY-15533
LY 3000328Cathepsin S Inhibitor -
HY-10042
OdanacatibCathepsin K Inhibitor -
HY-15100
BalicatibCathepsin K Inhibitor -
HY-103352
L-006235Cathepsin K Inhibitor -
HY-N2905
Aurantiamide acetateCathepsin Inhibitor -
HY-100231
Cathepsin inhibitor 1Cathepsin Inhibitor -
HY-109069
PetesicatibCathepsin S Inhibitor -
HY-118762
KGP94Cathepsin L Inhibitor -
HY-102087
JPM-OEtCysteine Cathepsin Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 262381-84-0
-
Peso molecular 392.45
-
Fòrmula C20H28N2O6
-
SMILES
O=C([C@H]1O[C@@H]1C(N[C@H](C(NCCC2=CC=C(O)C=C2)=O)CC(C)C)=O)OCC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Withana NP, et al. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res. 2012 Mar 1;72(5):1199-209. [Content Brief]
[2]. Bell-McGuinn KM, et al. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. Cancer Res. 2007 Aug 1;67(15):7378-85. [Content Brief]
[3]. Schurigt U, et al. Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model. Biol Chem. 2008 Aug;389(8):1067-74. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
JPM-OEt (Standard) Related Classifications
HY-102087R Related Classifications
Powered by Bioz